The use of economic evaluations in NHS decision-making: a review and empirical investigation.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 18373906)

Published in Health Technol Assess on April 01, 2008

Authors

I Williams1, S McIver, D Moore, S Bryan

Author Affiliations

1: Health Economics Facility, University of Birmingham, UK.

Articles citing this

A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res (2014) 3.49

The economic effect of extracorporeal membrane oxygenation to support adults with severe respiratory failure in Brazil: a hypothetical analysis. Rev Bras Ter Intensiva (2014) 1.78

From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking. Cost Eff Resour Alloc (2012) 1.78

New directions in evidence-based policy research: a critical analysis of the literature. Health Res Policy Syst (2014) 1.61

Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients. Cost Eff Resour Alloc (2010) 1.30

Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res (2011) 1.06

Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol (2008) 1.04

Lonely at the top and stuck in the middle? The ongoing challenge of using cost-effectiveness information in priority setting : Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden". Int J Health Policy Manag (2015) 0.93

The use (or rather the non-use) of cost-effectiveness data in priority setting decisions - are we underestimating the barriers to using health economics in real world priority setting decisions?: Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden". Int J Health Policy Manag (2015) 0.91

Estimating cost-effectiveness in public health: a summary of modelling and valuation methods. Health Econ Rev (2012) 0.83

Issues in the incorporation of economic perspectives and evidence into Cochrane reviews. Syst Rev (2013) 0.82

Economic evaluations of personalized medicine: existing challenges and current developments. Pharmgenomics Pers Med (2015) 0.82

How do government health departments in Australia access health economics advice to inform decisions for health? A survey. Aust New Zealand Health Policy (2009) 0.78

The challenge of obtaining information necessary for multi-criteria decision analysis implementation: the case of physiotherapy services in Canada. Cost Eff Resour Alloc (2013) 0.78

Engaging with economic evaluation methods: insights from small and medium enterprises in the UK medical devices industry after training workshops. Health Res Policy Syst (2012) 0.78

Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space. PLoS One (2015) 0.78

Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities. PLoS One (2016) 0.77

Is AF Ablation Cost Effective? J Atr Fibrillation (2010) 0.75

Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles. J Mark Access Health Policy (2016) 0.75

Is AF Ablation Cost Effective? J Atr Fibrillation (2010) 0.75

Sustainability in Health care by Allocating Resources Effectively (SHARE) 7: supporting staff in evidence-based decision-making, implementation and evaluation in a local healthcare setting. BMC Health Serv Res (2017) 0.75

Articles by these authors

(truncated to the top 100)

The nucleotide sequence of the cloned rpoD gene for the RNA polymerase sigma subunit from E coli K12. Nucleic Acids Res (1981) 5.52

Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet (2001) 4.96

Lead poisoning among low-income children in Orange County, California. A need for regionally differentiated policy. JAMA (1993) 3.77

Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ (2007) 3.30

Phase II/III randomized trial of TCH346 in patients with ALS. Neurology (2007) 3.22

Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess (2006) 2.54

Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol (1992) 2.45

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess (2005) 2.42

Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ (2005) 2.41

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess (2008) 2.34

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut (2011) 2.14

Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia (2011) 2.06

EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care (2001) 2.06

Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess (2007) 2.06

A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda. Int J Tuberc Lung Dis (2009) 2.02

Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol (1995) 1.96

Animal companions and one-year survival of patients after discharge. Public Health Rep (1982) 1.93

The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res (1998) 1.88

Treatment of natal cleft sinus: a prospective clinical and economic evaluation. BMJ (1992) 1.82

Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst (1998) 1.81

Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. Nat Struct Biol (1997) 1.80

A critical evaluation of HIPE data. Ir Med J (2012) 1.77

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol (2009) 1.75

Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol (1999) 1.71

Mammography screening: an incremental cost effectiveness analysis of double versus single reading of mammograms. BMJ (1996) 1.70

RNA-dependent DNA polymerase activity in virus-like particles isolated from human milk. Nature (1971) 1.63

Location of an F-pilin pool in the inner membrane. J Bacteriol (1981) 1.58

Aorto-left renal vein fistula: is there a place for endovascular management? J Endovasc Surg (1999) 1.57

Dark matter search results from the CDMS II experiment. Science (2010) 1.57

A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1. Health Technol Assess (2006) 1.56

The association of age and semen quality in healthy men. Hum Reprod (2003) 1.52

Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant. Cancer (1998) 1.52

The alteration of serum potassium level during sample transit. Practitioner (1989) 1.51

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res (1993) 1.51

Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiat Res (1995) 1.48

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. Health Technol Assess (2002) 1.48

Incubation periods for paediatric AIDS patients. Nature (1988) 1.47

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer. J Clin Oncol (2000) 1.47

Autoimmune enteropathy with anti-goblet cell antibodies. Hum Pathol (1995) 1.47

Riluzole for motor neurone disease. More trials are needed. BMJ (2001) 1.47

Radiography of facial trauma, the lateral view is not required. Clin Radiol (1998) 1.46

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46

Cerebral abscesses in a patient with AIDS caused by methicillin-resistant Staphylococcus aureus (MRSA) Int J STD AIDS (1997) 1.45

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess (2008) 1.43

A randomized double-blind study of the effect of distant healing in a population with advanced AIDS. Report of a small scale study. West J Med (1998) 1.43

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation. Health Technol Assess (2011) 1.43

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. Health Technol Assess (2006) 1.42

Human papillomavirus typing in HIV-positive women. Infect Dis Obstet Gynecol (2001) 1.41

Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour. BJOG (2010) 1.41

Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol (1992) 1.40

Chromosomes of human sperm: variability among normal individuals. Hum Genet (1985) 1.40

Two cases of near asphyxiation in children, using non-releasing plastic garden ties. Emerg Med J (2001) 1.39

Between a rock and a hard place: exploring the conflict between respecting the privacy of patients and informing their carers. Intern Med J (2009) 1.39

Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol Microbiol (2001) 1.39

Requirements for training to ensure competence of endoscopists performing invasive procedures in children. J Pediatr Gastroenterol Nutr (1998) 1.38

Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health Technol Assess (2009) 1.38

The effect of tra mutations on the synthesis of the F-pilin membrane polypeptide. Mol Gen Genet (1981) 1.34

erbB-2 (HER-2) and breast cancer progression. Appl Immunohistochem Mol Morphol (2003) 1.33

Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol (2008) 1.32

A new activity in the Ftra operon which is required for F-pilin synthesis. Mol Gen Genet (1982) 1.32

The effect of a picture archiving and communications system (PACS) on diagnostic performance in the accident and emergency department. J Accid Emerg Med (2000) 1.31

Rapid human chromosome aberration analysis using fluorescence in situ hybridization. Int J Radiat Biol (1989) 1.28

Experimental study of a novel fibrin sealant for achieving haemostasis following partial hepatectomy. Br J Surg (2000) 1.28

Changes in period mRNA levels in the brain and division of labor in honey bee colonies. Proc Natl Acad Sci U S A (2000) 1.28

Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess (2010) 1.26

Transmission of genetically diverse strains of HIV-1 in Pune, India. Indian J Med Res (1998) 1.26

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol (1996) 1.25

Influence of maternal education on child immunization and stunting in Kenya. Matern Child Health J (2011) 1.25

Analysis of transfer genes and gene products within the traB-traC region of the Escherichia coli fertility factor, F. J Bacteriol (1987) 1.23

Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci U S A (1991) 1.22

Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience. Pharmacoeconomics (1999) 1.21

Role of outer-membrane cytochromes MtrC and OmcA in the biomineralization of ferrihydrite by Shewanella oneidensis MR-1. Geobiology (2009) 1.21

Trench-shaped binding sites promote multiple classes of interactions between collagen and the adherence receptors, alpha(1)beta(1) integrin and Staphylococcus aureus cna MSCRAMM. J Biol Chem (1999) 1.19

Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma. Cancer Chemother Pharmacol (2007) 1.19

Historic low Haemophilus influenzae type B case tally--Canada 2000. Can Commun Dis Rep (2001) 1.17

Analysis of Escherichia coli K12 F factor transfer genes: traQ, trbA, and trbB. Plasmid (1987) 1.17

Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.17

Structure of human factor D. A complement system protein at 2.0 A resolution. J Mol Biol (1994) 1.17

Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. J Mol Biol (1998) 1.16

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol (1989) 1.16

Eosinophilic gastroenteritis presenting in an adolescent with isolated colonic involvement. Gut (1986) 1.16

Is Mycobacterium bovis in the environment important for the persistence of bovine tuberculosis? Biol Lett (2006) 1.16

Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice. Clin Chem (1996) 1.15

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technol Assess (2004) 1.14

Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res (1993) 1.14

Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.14

Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst (1992) 1.14

Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry (1994) 1.13

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technol Assess (2001) 1.13

Synthesis of F-pilin polypeptide in the absence of F traJ product. Plasmid (1984) 1.12

Phase I trial of Taxotere: five-day schedule. J Natl Cancer Inst (1992) 1.12

Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol (2000) 1.12

Genes and gene products involved in the synthesis of F-pili. Basic Life Sci (1985) 1.12

Spouses as observers of the events in their relationship. J Consult Clin Psychol (1981) 1.11

Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet (1997) 1.11

A comparison of image reject rates when using film, hard copy computed radiography and soft copy images on picture archiving and communication systems (PACS) workstations. Br J Radiol (1999) 1.10

Physiology of F-pilin synthesis and utilization. J Bacteriol (1983) 1.10

Sexually abused children in a national survey of parents: methodological issues. Child Abuse Negl (1997) 1.09

An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol (1993) 1.09